FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094688 [Registered on: 12/09/2025] Trial Registered Prospectively
Last Modified On: 11/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   How Night Shifts Affect Digestion: An Ayurvedic Study on Body Clock Imbalance and Natural Treatments for Amlapitta 
Scientific Title of Study   A Cross-Sectional Observational Study of Association between Circadian Rhythm Alteration and Doshic Imbalance in Night Workers having Amlapitta and A Clinical Comparative Study to Evaluate the Effect of Yavadi Kwatha and Amlapitta Mishran in Amlapitta 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Suryawanshi Payal Prataprao 
Designation  PhD SCHOLAR 
Affiliation  National Institute of Ayurveda 
Address  Department of Roga Nidana Evam Vikriti Vigyana, OPD no 06 and 17, National Institute Of Ayurveda Deemed To Be University, Jorawar Singh Gate, Amer Road

Jaipur
RAJASTHAN
302002
India 
Phone  7387993301  
Fax    
Email  payalps234@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Balkrishan Sevatkar 
Designation  Professor 
Affiliation  National Institute of Ayurveda 
Address  Department of Roga Nidana Evam Vikriti Vigyana, OPD no 06 and 17, National Institute Of Ayurveda Deemed To Be University, Jorawar Singh Gate, Amer Road

Jaipur
RAJASTHAN
302002
India 
Phone  9352311105  
Fax    
Email  drbks6@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Suryawanshi Payal Prataprao 
Designation  PhD SCHOLAR 
Affiliation  National Institute of Ayurveda 
Address  Department of Roga Nidana Evam Vikriti Vigyana, OPD no 06 and 17, National Institute Of Ayurveda Deemed To Be University, Jorawar Singh Gate, Amer Road


RAJASTHAN
302002
India 
Phone  7387993301  
Fax    
Email  payalps234@gmail.com  
 
Source of Monetary or Material Support  
National Institute Of Ayurveda Deemed To Be University, Jorawar Singh Gate, Amer Road 302002, Jaipur, Rajasthan, Inida 
 
Primary Sponsor  
Name  National Institute of Ayurveda 
Address  Jorawar Singh Gate, Amer Road, 302002, Jaipur, Rajasthan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
SURYAWANSHI PAYAL PRATAPRAO  National Institute of Ayurveda  OPD no 17 and Opd 6, Department of Roga Nidana Evam Vikriti Vigyana, Jorawar Singh Gate, Amer Road, 302002
Jaipur
RAJASTHAN 
07387993301

payalps234@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE NATIONAL INSTITUTE OF AYURVEDA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K297||Gastritis, unspecified. Ayurveda Condition: AMLAPITTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugOther than Classical(1) Medicine Name: Amlapitta Mishran, Reference: NA, Route: Oral, Dosage Form: Sharkara/ Syrup, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Yavadi Kwath, Reference: Mishra S.N. Bhaisajya Ratnavali of Sen Govind D. 1st edition. Varanasi; Chaukhamba Surbharti Prakashan; 2012. Adhyaya 56, Amlapittarogadhikar 901p, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Night workers of either sex
Presence of Amlapitta as diagnosed by Amlapitta Symptom Rating Scale Score of 5 or more
Participants willing to give written informed consent.
Currently engaged in night shift work (Ratrojagaran will be considered 12 pm to 6am minimum of 3 months, more than 5 nights/month)
 
 
ExclusionCriteria 
Details  Pregnant or lactating women.

Participants with documented H pylori infection.

Participants with history of psychiatric disorders including eating disorders.

Participants documented with chronic degenerative diseases including uncontrolled hepatic, renal or endocrine diseases (except diabetes controlled by oral hypoglycaemic agents or controlled hypothyroidism) malabsorption or chronic diarrhoea, history of seizures or epilepsy, gastric surgery or participants with oncological diseases.

Participants with history of gastroesophageal surgery and surgery to reduce the secretion of gastric acid.

Participants with history of oesophageal varix (varices)

Participants with history of malignant neoplasm of gastrointestinal tract.

Participants with history of thrombosis or administered with anti-thrombotic drugs.

Participants administered with H2 receptor antagonists, muscarinic receptor antagonists, gastrin receptor antagonist, proton pump inhibitors, prostaglandins or mucosal protective agents prior to study in 1 weeks.

Participants with history of Zollinger-Ellison syndrome

Participants documented with auto-immune disease, uncontrolled hypertension, Diabetes mellitus requiring insulin injections and chronic severe respiratory disease.

History of life threatening cardiovascular and /or neurological event in the past one year.

Participants with history of drug abuse, bleeding disorder.

Participants who cannot give valid consent such as mentally retarded, unconscious participants and psychiatric illness.

Known history of positive screening result for hepatitis B and/or Hepatitis C virus.

History of HIV or any immune deficient conditions.

Participants on corticosteroid, sleep medication, antipsychotic drugs.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in the Amlapitta Symptom Rating Scale score compared to baseline  30 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Enhancing awareness of circadian health and Dosha management through Ayurvedic principles.
Change in the PPDS symptom scale compared to baseline
Change in the EPS symptom scale compared to baseline
Change in the GERD scale compared to baseline
 
30 Days 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   05/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

PHASE 1 OBSERVATIONAL STUDY

 

RESEARCH QUESTION:

                            Is there any association between doshic imbalance and circadian rhythm alteration among night workers having Amlapitta

HYPOTHESIS

  Null Hypothesis [H01]- There is no association between doshic imbalance and circadian rhythm alteration among night workers having Amlapitta.

                                   Alternative Hypothesis [HA] There is association between doshic imbalance and circadian rhythm alteration among night workers having Amlapitta.

4.      AIM: To study the association between circadian rhythm alteration and doshic imbalance among night workers having Amlapitta.

 

  Primary Objective

To correlate serum cortisol levels with circadian rhythm alteration and doshic imbalance as a biomarker of physiological stress.

Secondary Objectives

  • To assess the distribution of chronotypes (morning, intermediate, evening types) among night workers using the Morningness-Eveningness Questionnaire (MEQ).[i]
  • To identify the predominant doshic imbalance (Vata, Pitta, Kapha, or their combinations) associated with circadian rhythm disturbances.
  • To explore the relationship between the degree of circadian misalignment and the severity of doshic imbalance.

PHASE 2 CLINICAL STUDY

 

                           RESEARCH QUESTION:

Is there any difference in efficacy of Yavadi Kwatha and Amlapitta Mishran in management of Amlapitta among night workers?

HYPOTHESIS:                              

      Null Hypothesis [H01]:

There is no difference in the efficacy of Yavadi Kwatha and Amlapitta Mishran in managing Amlapitta in night workers.

          Alternate Hypothesis [HA]:

There is a difference in the efficacy of Yavadi Kwatha and Amlapitta Mishran in managing Amlapitta in night workers.

 

                                             AIM:

To compare difference in the efficacy of Yavadi Kwatha and Amlapitta Mishran in managing Amlapitta among night workers.

 

                      OBJECTIVES:

Primary Objective:

   To evaluate efficacy of Yavadi Kwatha and Amlapitta Mishran Suspension in improvement of Amlapitta Symptom Rating Scale from baseline to day 30.

Secondary Objectives                                      

To evaluate efficacy of Yavadi Kwatha and Amlapitta Mishran Suspension in improvement of Post Prandial Distress Syndrome (PPDS) score from baseline to day 30.

 To evaluate efficacy of Yavadi Kwatha and Amlapitta Mishran Suspension in improvement of Epigastric Pain Syndrome (EPS) score from baseline to day 30.

To assess the safety of Yavadi Kwatha and Amlapitta Mishran Suspension on GERD Scale score from baseline to day 30.

ASSESSMENT CRITERIA 

Amlapitta Symptom Ratings Scale: Scale of 0-21

 

Grades of severity

Score

Characteristics

Avipaak (Indigestion)

G0

0

no indigestion

G1

1

digests normal usual diet in 09 hours

G2

2

digests normal usual diet in 12 hours

G3

3

digests normal usual diet in 24 hours or more

Klama (Tiredness)

G0

0

no tiredness

G1

1

feel tired after exertion work

G2

2

feel tired after normal work

G3

3

feel tired even after taking rest

Utklesha (Nausea)

G0

0

no nausea

G1

1

Feel nausea after eating some peculiar food

G2

2

feel nausea after eating all kinds of food

G3

3

full day nausea, not related to eating

Tikta amla udgaar (Sour and bitter belching)

G0

0

no sour and bitter belching

G1

1

sour and bitter belching after taking spicy food

G2

2

sour and bitter belching after taking any type of food

G3

3

sour and bitter belching having no relation with food intake

Guruta (Feeling of heaviness in the body)

G0

0

no feeling of heaviness in the body

G1

1

heaviness after taking more quantity of heavy food

G2

2

heaviness even after taking light food

G3

3

heaviness even on empty stomach

Hrit-Kantha Daha (Burning sensation)

G0

0

no Burning sensation

G1

1

burning sensation after intake of spicy food

G2

2

feeling of burning sensation even after intake of normal food

G3

3

burning sensation even empty stomach

Aruchi (Anorexia)

G0

0

no anorexia

G1

1

eat food only two times without any snacks in between

G2

2

eat only once

G3

3

have no feeling of appetite

Total score range: 0-21


Functional Dyspepsia is divided into Postprandial Distress Syndrome (PPDS) and Epigastric Pain Syndrome (EPS). Criteria for PPDS and EPS will be recorded on a Likert scale to see improvement in the symptoms at the end of treatment.

Postprandial Distress Syndrome (PPDS) Diagnostic Criteria score:

     Bothersome postprandial fullness severe enough to impact on usual activities) – Likert scale of 1 (very mild) to 5 (very severe).

     Bothersome early satiation severe enough to prevent finishing a regular-size meal) – Likert scale of 1 (very mild) to 5 (very severe).

Epigastric Pain Syndrome (EPS) Diagnostic criteria score:

  Bothersome epigastric pain severe enough to impact on usual activities) - Likert scale of 1 (very mild) to 5 (very severe).

   Bothersome epigastric burning severe enough to impact on usual activities) - Likert scale of 1 (very mild) to 5 (very severe)


GERD Health Related Quality of Life (GERD HRQL) Questionnaire

 
Close